PE20030552A1 - THERAPEUTIC APPLICATION OF SELECTIVE AGONISTS OF THE ESTROGENORECEPTOR BETA (ERß) TO CAUSE SOMATOTROPES, ORGANOTROPES AND ANTIATABOLIC EFFECTS - Google Patents
THERAPEUTIC APPLICATION OF SELECTIVE AGONISTS OF THE ESTROGENORECEPTOR BETA (ERß) TO CAUSE SOMATOTROPES, ORGANOTROPES AND ANTIATABOLIC EFFECTSInfo
- Publication number
- PE20030552A1 PE20030552A1 PE2002001035A PE2002001035A PE20030552A1 PE 20030552 A1 PE20030552 A1 PE 20030552A1 PE 2002001035 A PE2002001035 A PE 2002001035A PE 2002001035 A PE2002001035 A PE 2002001035A PE 20030552 A1 PE20030552 A1 PE 20030552A1
- Authority
- PE
- Peru
- Prior art keywords
- organotropes
- estrogenoreceptor
- antiatabolic
- erß
- somatotropes
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A LA PREPARACION DE UN MEDICAMENTO MEDIANTE EL USO DE AGONISTAS SELECTIVOS DEL ESTROGENORECEPTOR (ERß), TAL COMO 8ß-VINIL-1,3,10-ESTRATRIEN-3,17ß-DIOL, PARA PROVOCAR EFECTOS SOMATOTROPOS Y/O ORGANOTROPOS EN EL SISTEMA NERVIOSO CENTRAL, EL SISTEMA CIRCULATORIO, OSEO Y/O INMUNOLOGICO EN EL ORGANISMO DE UNA PERSONA DE LA TERCERA EDAD (TERAPIA ANTICATABOLICA). ASIMISMO, DICHO MEDICAMENTO ESTIMULA LA HORMONA DEL CRECIMIENTO, IGF-I, INFLUYE EN EL CRECIMIENTO DE LA MASA MUSCULAR Y LA MASA OSEA, ENTRE OTROSREFERS TO THE PREPARATION OF A MEDICINAL PRODUCT BY USING SELECTIVE AGONISTS OF THE ESTROGENORECEPTOR (ERß), SUCH AS 8ß-VINYL-1,3,10-ESTRATRIEN-3,17ß-DIOL, TO CAUSE SOMATOTROPES AND / OR ORGANOTROPES EFFECTS IN THE CENTRAL NERVOUS SYSTEM, THE CIRCULATORY, OSEO AND / OR IMMUNOLOGICAL SYSTEM IN THE ORGANISM OF A PERSON OF THE THIRD AGE (ANTIATABOLIC THERAPY). ALSO, SAID MEDICINE STIMULATES THE GROWTH HORMONE, IGF-I, INFLUENCES THE GROWTH OF MUSCLE MASS AND BONE MASS, AMONG OTHERS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33152901P | 2001-11-19 | 2001-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030552A1 true PE20030552A1 (en) | 2003-07-16 |
Family
ID=38813415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002001035A PE20030552A1 (en) | 2001-11-19 | 2002-10-21 | THERAPEUTIC APPLICATION OF SELECTIVE AGONISTS OF THE ESTROGENORECEPTOR BETA (ERß) TO CAUSE SOMATOTROPES, ORGANOTROPES AND ANTIATABOLIC EFFECTS |
Country Status (2)
Country | Link |
---|---|
PE (1) | PE20030552A1 (en) |
UY (1) | UY27508A1 (en) |
-
2002
- 2002-10-21 PE PE2002001035A patent/PE20030552A1/en not_active Application Discontinuation
- 2002-10-21 UY UY27508A patent/UY27508A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY27508A1 (en) | 2003-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145487A0 (en) | Apomorphine and sildenafil composition | |
NO332893B1 (en) | Use of antibody for the preparation of drug for use in CVP chemotherapy | |
EP1728863A3 (en) | C-class oligonucleotide analogs with enhanced immunostimulatory potency | |
EP0804595A4 (en) | ||
IL173369A (en) | Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells | |
BR9406893A (en) | Use of ninth- and decapeptides for the preparation of a medicine to fight AIDS | |
ES2101106T3 (en) | METHOD FOR STIMULATING THE IMMUNE RESPONSE. | |
GB0109297D0 (en) | Vaccine | |
WO2004087065A8 (en) | Compositions for induction of a therapeutic response | |
AU8180001A (en) | Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells | |
MY109309A (en) | Improvements in or relating to somatostatins | |
BRPI0418157A (en) | allogeneic tumor therapy | |
ITMI20031617A1 (en) | MICROCAPSULE WITH DOUBLE LAYER OF USE POLISACCHARIDES | |
CO5251425A1 (en) | METHOD AND COMPOSITIONS TO ADMINISTER TAXANS ORALLY TO HUMAN PATIENTS | |
CA2319542A1 (en) | The treatment of sexual dysfunction in certain patient groups | |
PE20030552A1 (en) | THERAPEUTIC APPLICATION OF SELECTIVE AGONISTS OF THE ESTROGENORECEPTOR BETA (ERß) TO CAUSE SOMATOTROPES, ORGANOTROPES AND ANTIATABOLIC EFFECTS | |
ES2042818T3 (en) | THERAPEUTIC AGENT FOR THROMBOCITOPENIA. | |
AR048318A1 (en) | ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA | |
CN211634236U (en) | Composite energy meridian brush | |
FR2786699B1 (en) | MEDICINE, IN PARTICULAR FOR PREVENTING OR TREATING SEXUAL DYSFUNCTIONS | |
AR029337A1 (en) | USE OF INTERFERON ALFA PEGILADO FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THERAPY AGAINST HIV | |
AR109456A2 (en) | USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY | |
Butakhonov | APITHERAPY IN NEUROLOGY | |
ES2031930T3 (en) | A METHOD TO OBTAIN A LYOPHILIZED PREPARATION CONTAINING ASPOXICILLIN AS AN ACTIVE INGREDIENT. | |
CN2212418Y (en) | Chinese medicine plaster for quickly stopping dizziness |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |